137 related articles for article (PubMed ID: 25467776)
21. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
[TBL] [Abstract][Full Text] [Related]
23. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
24. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
[TBL] [Abstract][Full Text] [Related]
25. The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis.
Guimarães LM; Diniz MG; Rogatto SR; Gomez RS; Gomes CC
J Oral Pathol Med; 2021 Aug; 50(7):632-638. PubMed ID: 33217066
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
Sun Z; Gong Y; Huang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
[TBL] [Abstract][Full Text] [Related]
27. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
29. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma.
Haya-Fernández MC; Bagán JV; Murillo-Cortés J; Poveda-Roda R; Calabuig C
Oral Dis; 2004 Nov; 10(6):346-8. PubMed ID: 15533209
[TBL] [Abstract][Full Text] [Related]
31. Loss of p53 gene as a biomarker of high risk oral leukoplakias.
Saranath D; Tandle AT; Deo MG; Mehta AR; Sanghvi V
Indian J Biochem Biophys; 1997 Jun; 34(3):266-73. PubMed ID: 9425746
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic biomonitoring in oral leukoplakia patients with mild dysplasia.
Sánchez-Siles M; Camacho-Alonso F; Ros-Llor I; López-Jornet P
Int J Dermatol; 2014 Dec; 53(12):1454-9. PubMed ID: 24898883
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
[TBL] [Abstract][Full Text] [Related]
34. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.
Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
[TBL] [Abstract][Full Text] [Related]
36. Chromosome instability predicts the progression of premalignant oral lesions.
Siebers TJ; Bergshoeff VE; Otte-Höller I; Kremer B; Speel EJ; van der Laak JA; Merkx MA; Slootweg PJ
Oral Oncol; 2013 Dec; 49(12):1121-8. PubMed ID: 24075955
[TBL] [Abstract][Full Text] [Related]
37. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
[TBL] [Abstract][Full Text] [Related]
38. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma.
Fillies T; Jogschies M; Kleinheinz J; Brandt B; Joos U; Buerger H
Oncol Rep; 2007 Sep; 18(3):639-43. PubMed ID: 17671713
[TBL] [Abstract][Full Text] [Related]
39. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
40. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma.
Cervigne NK; Reis PP; Machado J; Sadikovic B; Bradley G; Galloni NN; Pintilie M; Jurisica I; Perez-Ordonez B; Gilbert R; Gullane P; Irish J; Kamel-Reid S
Hum Mol Genet; 2009 Dec; 18(24):4818-29. PubMed ID: 19776030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]